archetype (adl_version=1.4; uid=ae335549-7d58-4f6f-ae15-5af78c06214a)
	openEHR-EHR-CLUSTER.figo_staging_cancer.v0

concept
	[at0000]	-- FIGO staging system for gynecological cancer
language
	original_language = <[ISO_639-1::en]>
	translations = <
		["nb"] = <
			language = <[ISO_639-1::nb]>
			author = <
			>
		>
	>
description
	original_author = <
		["name"] = <"Hanne Marte Sandal Bårholm">
		["organisation"] = <"Helse Vest IKT">
		["email"] = <"hanne.marte.sandal.barholm@helse-vest-ikt.no">
		["date"] = <"2024-04-29">
	>
	details = <
		["nb"] = <
			language = <[ISO_639-1::nb]>
			purpose = <"For å registrere FIGO stadium for gynekologisk kreft.">
			use = <"Brukes for å registrere FIGO stadium for gynekologisk kreft.

Arketypen er laget for å benyttes i en ENTRY arketype som vil gi den kliniske eller patologiske konteksten for FIGO registreringen. For eksempel: I SLOTet \"Spesifikke detaljer\" i arketypen EVALUATION.problem_diagnose (Problem/diagnose), i en relevant patologirelatert CLUSTER-arketype som igjen nøstes i laboratoriesvar-arketypen (OBSERVATION.laboratory_test_result), i arketypen OBSERVATION.imaging_exam_result (Bildediagnostisk svar) eller innen andre ENTRY- eller CLUSTER-arketyper der det er klinisk passende.

Hver kreftform har et sett av unike FIGO klassifikasjonsverdier. Det antas at denne arketypen blir tilpasset for å ivareta de unike kravene til hver tumortype i henhold til aktuell utgave av FIGO-klassifikasjonen. Dette vil gjøres enten ved å bruke en spesialisering av arketypen eller i et templat.">
			keywords = <"figo, vulva, vagina, livmorhals, eggstokk, livmor, gynekologi, klassifisering, stadium, kreft, neoplasi, onkologi", ...>
			misuse = <"">
			copyright = <"© openEHR Foundation">
		>
		["en"] = <
			language = <[ISO_639-1::en]>
			purpose = <"To record the FIGO stage for gynecological cancer.">
			use = <"Use to record the FIGO stage for gynecological cancer.

This archetype has been designed to be nested inside an ENTRY or appropriate CLUSTER archetype which will provide a clinical or pathological context for the FIGO stage - for example: the 'Specific details' SLOT within the EVALUATION.problem_diagnosis archetype; an appropriate histopathology-related CLUSTER archetype within the OBSERVATION.laboratory_test_result archetype context; within the OBSERVATION.imaging_exam_result archetype; or within other ENTRY or CLUSTER archetypes, where clinically appropriate.

Each cancer has a set of unique FIGO staging values. It is expected that this archetype will be further constrained to reflect the unique requirements for each tumour and version of the FIGO staging system, using either an archetype specialisation or a template.">
			keywords = <"figo, vulva, vagina, cervix, ovary, uterus, gynecology, classification, stage, staging, cancer, neoplasia, oncology", ...>
			misuse = <"">
			copyright = <"© openEHR Foundation">
		>
	>
	lifecycle_state = <"in_development">
	other_contributors = <>
	other_details = <
		["licence"] = <"This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.">
		["custodian_organisation"] = <"openEHR Foundation">
		["references"] = <"Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet. 2023 Aug;162(2):383-394. doi: 10.1002/ijgo.14923. Epub 2023 Jun 20. Erratum in: Int J Gynaecol Obstet. 2023 Oct 6. doi: 10.1002/ijgo.15193. PMID: 37337978.

Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):61-85. doi: 10.1002/ijgo.13878. PMID: 34669199; PMCID: PMC9298325.

Olawaiye AB, Cotler J, Cuello MA, Bhatla N, Okamoto A, Wilailak S, Purandare CN, Lindeque G, Berek JS, Kehoe S. FIGO staging for carcinoma of the vulva: 2021 revision. Int J Gynaecol Obstet. 2021 Oct;155(1):43-47. doi: 10.1002/ijgo.13880. PMID: 34520062; PMCID: PMC9290586.

Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):19-27. doi: 10.1002/ijgo.13867. PMID: 34669198; PMCID: PMC9298013.

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, Sankaranarayanan R, Brierley J, Mutch D, Querleu D, Cibula D, Quinn M, Botha H, Sigurd L, Rice L, Ryu HS, Ngan H, Mäenpää J, Andrijono A, Purwoto G, Maheshwari A, Bafna UD, Plante M, Natarajan J. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019 Apr;145(1):129-135. doi: 10.1002/ijgo.12749. Epub 2019 Jan 17. Erratum in: Int J Gynaecol Obstet. 2019 Nov;147(2):279-280. doi: 10.1002/ijgo.12969. PMID: 30656645.">
		["original_namespace"] = <"org.openehr">
		["original_publisher"] = <"openEHR Foundation">
		["custodian_namespace"] = <"org.openehr">
		["MD5-CAM-1.0.1"] = <"21CADD22A4DFBD15B173994D01DD9AC6">
		["build_uid"] = <"218fd684-dab8-401a-87fc-1b839cf5ba43">
		["revision"] = <"0.0.1-alpha">
	>

definition
	CLUSTER[at0000] matches {    -- FIGO staging system for gynecological cancer
		items cardinality matches {1..*; unordered} matches {
			ELEMENT[at0005] occurrences matches {0..1} matches {    -- Cancer type
				value matches {
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0002] occurrences matches {0..1} matches {    -- FIGO stage
				value matches {
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0003] occurrences matches {0..*} matches {    -- Molecular subtype
				value matches {
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0006] occurrences matches {0..1} matches {    -- FIGO staging with molecular classification
				value matches {
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0004] occurrences matches {0..1} matches {    -- FIGO version
				value matches {
					DV_TEXT matches {*}
				}
			}
		}
	}


ontology
	term_definitions = <
		["en"] = <
			items = <
				["at0000"] = <
					text = <"FIGO staging system for gynecological cancer">
					description = <"A staging system for cancers of the female reproductive organs, published by The International Federation of Gynecology and Obstetrics (FIGO).">
				>
				["at0002"] = <
					text = <"FIGO stage">
					description = <"Assesment of the size and extent of the tumor, the involvement of nearby lymph nodes, and the presence or absence of distant metastases.">
				>
				["at0003"] = <
					text = <"Molecular subtype">
					description = <"Presence of molecular features affecting the FIGO stage.">
					comment = <"For example: POLEmut, MMRd, NSMP, and p53abn.">
				>
				["at0004"] = <
					text = <"FIGO version">
					description = <"The version of the FIGO staging system used for the assessment.">
					comment = <"For example: 2009.">
				>
				["at0005"] = <
					text = <"Cancer type">
					description = <"The tumour type of the FIGO staging.">
					comment = <"For example: ovarian, endometrial, cervical, vaginal or vulval cancer, gestational trophoblastic neoplasia, or sarcoma.">
				>
				["at0006"] = <
					text = <"FIGO staging with molecular classification">
					description = <"Concatenation of FIGO stage and molecular subtype with 'm' as delimiter.">
					comment = <"For example: IIImPOLEmut or IVmPOLEmut.">
				>
			>
		>
		["nb"] = <
			items = <
				["at0000"] = <
					text = <"FIGO stadieinndeling for gynekologisk kreft">
					description = <"Et stadieinndelingssystem for kreft i de kvinnelige kjønnsorganene utgitt av The International Federation of Gynecology and Obstetrics (FIGO).">
				>
				["at0002"] = <
					text = <"FIGO stadium">
					description = <"Vurdering av størrelse og utbredelse av tumor, involvering av nærliggende lymfeknuter, og tilstedeværelse eller fravær av fjernmetastaser.">
				>
				["at0003"] = <
					text = <"Molekylær subtype">
					description = <"Tilstedeværelse av molekylære egenskaper som påvirker FIGO stadiet.">
				>
				["at0004"] = <
					text = <"FIGO-versjon">
					description = <"Versjonen av FIGO stadieinndeling som er brukt for å bestemme FIGO stadiet.">
					comment = <"For eksempel: 2009.">
				>
				["at0005"] = <
					text = <"Krefttype">
					description = <"Krefttypen som klassifiseres etter FIGO stadieinndeling.">
					comment = <"For eksempel: ovariekreft, endometriekreft, livmorhalskreft, vaginakreft, vulvakreft, trofoblastisk kreft i svangerskapet eller sarkom.">
				>
				["at0006"] = <
					text = <"FIGO stadium med molekyær klassifisering">
					description = <"Sammentrekning av FIGO stadium og molekylær subtype med 'm' som skilletegn.">
					comment = <"For eksempel: IIImPOLEmut eller IVmPOLEmut.">
				>
			>
		>
	>
